Eli Lilly
LLY
LLY
2,657 hedge funds and large institutions have $288B invested in Eli Lilly in 2022 Q4 according to their latest regulatory filings, with 325 funds opening new positions, 949 increasing their positions, 1,003 reducing their positions, and 92 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2,657
Holders Change
+186
Holders Change %
+7.53%
% of All Funds
42.87%
Holding in Top 10
197
Holding in Top 10 Change
+10
Holding in Top 10 Change %
+5.35%
% of All Funds
3.18%
New
325
Increased
949
Reduced
1,003
Closed
92
Calls
$2.38B
Puts
$2.64B
Net Calls
-$260M
Net Calls Change
-$133M
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$1.35B |
| 2 |
BlackRock
New York
|
+$637M |
| 3 |
JPMorgan Chase & Co
New York
|
+$461M |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$446M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$313M |
